Barely Significant
← all excerpts

MYD88<sup>L265P</sup> and MYD88<sup>other</sup> variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma.

J Cancer Res Clin Oncol · 2023 · PMC10374827 · PMID 37093346

Europe PMCDOI
1
hedged sentence
0.0900
closest p · 1.8× alpha
0.0900
boldest claim

The sentences

showed a trendP = 0.090so close (0.05 < p ≤ 0.1)
Regarding OS, patients with MYD88 other also showed a trend to suffer worse outcome than those with MYD88 L265P (median OS: 39.5 months vs. not reached, HR = 2.46, P = 0.090) (Fig. 7 D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.